Notes from the Field: Posttreatment Lesions After Tecovirimat Treatment for Mpox — New York City, August–September 2022
by from Morbidity and Mortality Weekly Report (MMWR) on (#6B7F4)
This report describes treatment of lesions following completion of tecovirimat therapy for mpox.